Document:

Exhibit 4.23

    

     

    

    
      EMPLOYMENT AGREEMENT

      

      

      This Employment Agreement (“Agreement”) is entered into

          this on March 16, 2018 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Mr. James Tonra (“Employee”) (collectively, the “Parties”).

      

      

      WHEREAS, Employee and the Company desire to enter into an agreement in which Employee will be an employee of the Company;

      

      

      WHEREAS, the Company and Employee have agreed to certain terms and conditions,
          which are set forth below.

      

      

      AND NOW, intending to be legally bound, the Parties agree as follows:

      

      

      
        
          	

                	1.	
                  Position and

                        Duties

                

        

      

      

      

      a.      Employee shall serve and the Company shall employ Employee in the position of Senior Vice President, Preclinical
            Development. Employee shall report directly to Dr. Lan Huang, CEO (“Supervisor”). The duties of Employee shall be assigned by the Supervisor from time to
            time commensurate with Employee’s education, skills and experience.

      

      

      b.      Employee shall work full-time starting on April 02, 2018 and devote Employee’s best efforts to do the business of the Company in a manner that will further the interests of the Company.

      

      

      c.      Employee shall not work for any other person or entity while in the employ of the Company without prior written
            consent from the Supervisor.

      

      

      d.      Employee shall comply with all Company policies including, but not limited to, the attached Employee Handbook.

      

      

      
        
          	

                	2.	
                  Term and

                          Termination

                

        

      

      

      

      a.      Employee agrees to use his best efforts to remain employed with the Company for a minimum of 4 calendar years from the Effective

          Date.

      

      

      b.      Should Employee choose to resign
            voluntarily from the Company at any point in time, Employee agrees to give the Company a minimum of four (4) weeks written notice prior to Employee’s resignation date.

      

      

      c.      In the event that Employee does not

          give the Company four (4) weeks written notice prior to his resignation date, Employee
            agrees that the Company shall be entitled to withhold four (4) weeks of Employee’s
            salary.

       

          

      
        
          

      

      
      Employee’s employment may be terminated at any time and for any reason by
        action of the Supervisor, or any other officer of the Company, and the Parties agree that nothing in this Section
          shall change the “at-will” employment relationship between the Parties. After the introductory period, if the company decides to terminate your employment other than for Cause you shall be entitled to 3 months severance pay. Cause here is defined as: Continued failure to perform duties owed to the company; willful misconduct damaging
        to the company, its reputation or it products; intentional violation of any law or regulation. If the employee decides to resign from the company by himself, the employee will not get severance pay.

      

      

      3.            Compensation. Employee shall be paid a salary of $280,000
            annually, with the annual bonus up to 30% of the prorated annual salary, provided you reach the milestones to be determined between you and BeyondSpring. The
          Company will pay up to $500 per month towards the Employee’s healthcare coverage. Employee shall be entitled to participate in any salary increase program offered during
            employment with the Company, on a basis consistent with that applicable to other employees at Employee’s level, taking into account

            Employee’s position, duties and performance.

      

      

      
        
          	

                	4.	
                  Nonsolicitation.

                

        

      

      

      

      a.     Employee shall not, for a period of two (2) years after the date of
            Employee’s termination from the
          Company, directly or indirectly, solicit for hire any employees of the Company or induce any
            employees of the Company to terminate

            their relationship with the Company.

       

          

      b.      Employee agrees that Employee shall pay the Company the amount of Five Thousand Dollars ($5000) for each breach of Section 4.a. herein.

      

      

      
        
          	

                	5.	
                  Non-Disclosure of Confidential Information

                

        

      

      

      

      a.      The term Confidential Information means and includes any materials or information (whether in written, printed, graphic, video, audio, electronically stored, disk or other format) which (i) is not generally known to the public; (ii) was acquired or learned by Employee as a result of
        and during his relationship with Company at any time prior to or after the Effective Date; and (iii) relates to the business of Company and has actual or potential value to
        Company because it is not generally known. Without limiting the generality of the term, it includes any and all information made available to Employee in the course of his
        performance of services to Company prior to and after the Effective Date, including but not limited to all information relating to Company’s products, services, customers,
        employees, affiliates, suppliers, production processes, research, development, patents, copyrights, trademarks, intellectual property, finances, contracts, inventions, and actual and/or potential business opportunities; Company’s business plans and
        strategies; Company’s financing arrangements; and any other non-public information relating in any way to Company’s business or prospective business affairs. Confidential
        Information includes information or materials developed or acquired by Employee, alone or in concert with others, and also includes drafts, works-in-process, duplicates or
        reproductions of such information prior to and following the Effective Date.

       

          

      
        2

        
          

      

      b.      Employee agrees to hold and safeguard for the sole benefit of Company all Confidential Information acquired or developed
            by Employee. Employee will not, without the prior written consent of Company, during the

          term hereof or thereafter, misappropriate, use for his own advantage, disclose or otherwise make available Confidential Information to any person, except in the good faith performance of Employee’s duties during the term of the Agreement to persons having a need to know such information for the benefit of the Company.

      

      

      c.      Before disclosing Confidential Information under the compulsion of legal process, Employee agrees to give prompt
          notice to Company of the fact that Employee has been served with legal process which may require the disclosure of Confidential Information. The notice will

            be given within sufficient time before disclosure to permit Company to intervene in the matter or to take such other action as may be necessary to protect its interests and rights in its Confidential Information.

      

      

      d.      Upon the termination of the Agreement
            for any reason, Employee agrees to immediately return to Company all Confidential
            Information in any form or format in his possession or under his control. Employee
            agrees that he will not retain any copies or reproductions of Confidential
            Information in any form or format.

      

      

      
        
          	

                	6.	
                  Ownership of Inventions

                

        

      

      

      

      a.      All Inventions are the property of Company, and may be used, assigned, sold, patented or applied by Company without the
        approval of Employee or the payment of additional consideration. The term Inventions means all ideas, innovations, improvements, creations, discoveries, developments, concepts and designs (whether or not patentable) and all computer programs,
        software, insurance product applications, literary works, publications, audio/visual works, photographs, drawings, designs or other works (whether or not copyrightable) which relate to the business in which Company is engaged or plans to engage and
        which were created or conceived by Employee, alone or in concert with others, during the term of the Agreement.

      

      

      b.     Employee hereby assigns to Company Employee’s entire right, title and interest in and to all Inventions, without further
        consideration, free from any claim, lien for balance due, or rights of retention. During or after Employee’s employment, Employee agrees, upon request, to execute all documents necessary to evidence or effectuate such assignment; and further, to
        promptly and fully assist the Company in every lawful way, without additional compensation, but at Company’s expense, to obtain for the benefit of Company any patents, copyrights or other legal protection for such Inventions, including assisting in
        the preparation and filing of patent and copyright applications, giving testimony in legal proceedings and execution of all necessary documentation relating to obtaining, securing, defending and renewing such patents and copyrights

       

          

      7.             Notices. Any notice pursuant to this Agreement shall be in
            writing and shall be deemed given if delivered personally or sent by guaranteed overnight delivery service or registered or certified mail to the following
            addresses:

       

          

      To Employee: James Tonra, 12
            Williamsburg Court, Skillman, NJ 08558

      

      

      To Company: BeyondSpring Pharmaceuticals, Inc., 28 Liberty Street, 39th Floor, New York, NY 10005

       

          

      
        3

        
          

      

      or to such other addresses as either party may designate to the other in writing.

      

      

      8.             Governing Law. This Agreement is made under and shall be governed in its validity and
            interpretation by and in accordance with the substantive laws of the State of New York without giving effect to the principles of conflicts of laws.

      

      

      9.             Venue. Any dispute arising under this Employment Agreement shall be filed in the New York Supreme Court, New York County.

      

      

      10.         

        Severability. In case any provision hereof shall, for any reason , be held to be invalid, illegal or unenforceable in any respect , such invalidity, illegality or unenforceability shall not affect any other provision
          hereof, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had not been included herein. If any provision hereof shall, for
        any reason, be held by a court of competent jurisdiction to be excessively broad as to duration, geographical scope, activity or subject matter, it shall be construed by
        limiting and reducing it to make it enforceable to the extent compatible with applicable law as then in effect.

      

      

      11.           Entire Agreement. This Agreement constitutes the entire agreement between the Parties relating to the subject matter hereof and supersedes all prior negotiations, representations, agreements, proposals

          and understandings among the Parties with respect thereto.

      

      

      12.           Headings. The headings of the sections are for the convenience of reference only and shall not control or affect the meaning or construction or
            limit the scope or intent of any of the provisions of this Agreement.

      

      

      13.           Counterparts.
          This Agreement may be executed in several counterparts or with counterpart signature pages, each of which shall be
          deemed an original, but such counterparts shall together constitute one and the same Agreement.

       

          

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

       

        

      
        	/s/ James Tonra	
                 

              
	Employee	
                 

              
	
                 

              	
                 

              
	/s/ Lan Huang

              	
                 

              
	Company	 

      

      

      

      

      

      4Exhibit 10.1

    

    AMENDMENT NO. 1 TO WARRANT AGREEMENT

    

    

    This Amendment (this “Amendment”) is made as of April 29, 2019, by and between International Money Express, Inc. (formerly FinTech Acquisition Corp. II), a Delaware corporation (the “Company”) and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”), and constitutes an amendment to that certain Warrant Agreement, dated as of January 19, 2017 (the “Existing Warrant Agreement”), between the Company and the Warrant Agent.  Capitalized terms used but not otherwise defined in this Amendment shall have the meanings given to
        such terms in the Existing Warrant Agreement.

    

    

    WHEREAS,
        Section 9.8 of the Existing Warrant Agreement provides that the Company and the Warrant Agent may amend, subject to certain conditions provided therein, the Existing Warrant Agreement with written consent of the registered holders of at least
        sixty-five percent (65%) of the then outstanding Warrants;

    

    

    WHEREAS,
        the Company desires to amend the Existing Warrant Agreement to provide the Company with the right to require the holders of the Warrants to exchange all of the outstanding Warrants for a combination of 0.181 shares of Common Stock and $1.00 in
        cash, without interest, on the terms and subject to the conditions set forth herein; and

    

    

    WHEREAS,
        in the exchange offer and consent solicitation undertaken by the Company pursuant to the Registration Statement on Form S-4 filed with the Securities and Exchange Commission, the registered holders of more than sixty-five percent (65%) of the then
        outstanding Warrants consented to and approved this Amendment.

    

    

    NOW,
          THEREFORE, in consideration of the mutual agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto
        agree to amend the Existing Warrant Agreement as set forth herein.

    

    

    1.            Amendment of Existing Warrant Agreement.  The Existing Warrant Agreement is hereby amended as follows:

    

    

    1.1            Amend Section 2.5.  Section 2.5 is of the Existing
        Warrant Agreement is hereby amended by deleting the first sentence of Section 2.5.1 in its entirety and by inserting, in lieu thereof, the following:

     

      

    	 	
            “The Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the
                Sponsor, Cantor, or any of their respective Permitted Transferees (as defined below), the Placement Warrants: (a) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (b) shall not be redeemable by the
                Company except pursuant to Section 6A hereof, and (c) may not be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination (as defined below) except to a Permitted Transferee
                and the period during which the Placement Warrants held by Cantor are exercisable may not be extended (pursuant to the last sentence of Section 3.2 or otherwise) beyond the date that is five years from the effective date of the Registration
                Statement. For purposes of clarity, notwithstanding the provisions of Section 2.5(b) hereof, Placement Warrants may be subject to a Mandatory Exchange made pursuant to Section 6A hereof.”

          	 

    

    

    1

    

    
      
        

    

    

    

    1.2            Amend and Restate Section 6.4. Section 6.4 of the
        Existing Warrant Agreement is hereby amended by deleting Section 6.4 in its entirety and by insertion, in lieu thereof, the following:

     

      

    	 	
            “6.4  Exclusion of Placement
                    Warrants. The Company agrees that the redemption rights provided in this Section 6 (other than those set forth in Section 6A hereof) shall not apply to the Placement Warrants if at the time of the redemption such Placement
                Warrants continue to be held by the Sponsor, Cantor, or their Permitted Transferees; provided, however, that once such Placement
                Warrants are transferred (other than to Permitted Transferees under subsection 2.5), the Company may redeem the Placement Warrants, provided that the criteria for redemption are met, including the opportunity of the holder of such Placement
                Warrants to exercise the Placement Warrants prior to redemption pursuant to Section 6.3. Placement Warrants that are transferred to  persons other than Permitted Transferees shall, upon such transfer, cease to be Placement Warrants and
                shall become Public Warrants under this Agreement. For purposes of clarity, the exclusions of this Section 6.4 do not apply to any Mandatory Exchange made pursuant to Section 6A hereof. ”

          	 

     

      

    1.3            Add New Section 6A.  The Existing Warrant Agreement is
        hereby amended by adding a new Section 6A thereto, as follows:

    

    

    

      

    	 	
            “6A            Mandatory Exchange.

             

              

            6A.1 Company Election to
                    Exchange.  Notwithstanding any other provision in this Agreement to the contrary, all (and not less than all) of the outstanding Warrants may be exchanged, at the option of the Company, at any time while they are exercisable
                and prior to their expiration, at the office of the Warrant Agent, upon notice to the registered holders of the outstanding Warrants, as described in Section
                    6A.2 below, for a combination of 0.181 shares of Common Stock and  $1.00 in cash, without interest for each Warrant held by the holder thereof (the “Consideration”) (subject to equitable adjustment by the Company in the event of any stock splits, stock dividends, recapitalizations or similar transaction with respect to the Common Stock). 
                In lieu of issuing fractional shares, any holder of Warrants who would otherwise have been entitled to receive fractional shares as Consideration will, after aggregating all such fractional shares of such holder, be paid in cash (without
                interest) in an amount equal to such fractional part of a share multiplied by $11.99.

             

              

          	 
	 	
            6A.2 Date Fixed for, and Notice
                    of, Exchange.  In the event that the Company elects to exchange all of the Warrants, the Company shall fix a date for the exchange (the “Exchange Date”).  Notice of exchange shall be mailed by first class mail, postage prepaid, by the Company not less than fifteen (15) days prior to the Exchange Date to the registered holders of the
                Warrants at their last addresses as they shall appear on the registration books.  Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such
                notice.  The Company will make a public announcement of its election following the mailing of such notice.

             

              

          	 
	 	
            6A.3 Exercise After Notice of
                    Exchange.  The Warrants may be exercised, for cash at any time after notice of exchange shall have been given by the Company pursuant to Section
                    6A.2 hereof and prior to the Exchange Date.  On and after the Exchange Date, the registered holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Consideration.”

          	 

     

    

     

    

     2

    

    
      
        

    

     

    

    2.            Miscellaneous Provisions.

    

    

    2.1            Severability.  This Amendment shall be deemed
        severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Amendment or of any other term or provision hereof.  Furthermore, in lieu of any such invalid or unenforceable
        term or provision, the parties hereto intend that there shall be added as a part of this Amendment a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

    

    

    2.2            Applicable Law.  The validity, interpretation
        and performance of this Amendment shall be governed in all respects by the laws of the State of New York and without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. 
        The parties hereby agree that any action, proceeding or claim against it arising out of or relating in any way to this Amendment shall be brought and enforced in the courts of the State of New York or the United States District Court for the
        Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.  Each of the parties hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum

    

    

    2.3            Counterparts.  This Amendment may be executed
        in any number of counterparts, and by facsimile or portable document format (pdf) transmission, and each of such counterparts shall for all purposes be deemed to be an original and all such counterparts shall together constitute but one and the
        same instrument.

    

    

    2.4            Effect of Headings.  The Section headings
        herein are for convenience only and are not part of this Amendment and shall not affect the interpretation thereof.

    

    

    2.5            Entire Agreement.  The Existing Warrant
        Agreement, as modified by this Amendment, constitutes the entire understanding of the parties and supersedes all prior agreements, understandings, arrangements, promises and commitments, whether written or oral, express or implied, relating to the
        subject matter hereof, and all such prior agreements, understandings, arrangements, promises and commitments are hereby canceled and terminated.

    

    

    [Signatures on Next Page]

     

      

    3

    

    
      
        

    

    

    

    IN
          WITNESS WHEREOF, each of the parties has caused this Amendment to be duly executed as of the date first above written.

     

      

    	 	
            INTERNATIONAL MONEY EXPRESS, INC.

          
	 	 	 
	 	 By:       

            	
            /s/ Tony Lauro II

          
	 	 Name: 

            	
            Tony Lauro II

          
	 	 Title:	
            Chief Financial Officer

          
	 	 	 
	 	
            CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

          
	 	 	 
	 	By:  

            	
            /s/ Isaac J. Kagan

          
	 	Name: 

            	
            Isaac J. Kagan

          
	 	Title:	
            Vice President

          

    

    

    

    

    [Signature Page to Warrant Agreement Amendment]

     

      

     4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]